Fortis Healthcare has announced strong financial results for the quarter and financial year ended March 31, 2026. The company reported a significant 17.3% growth in consolidated revenues to INR 9,128 crore for FY26, with an operating EBITDA of INR 2,085 crore. A key highlight is the board’s recommendation of a dividend of INR 1 per share, reflecting the company’s strong operational performance and expansion across its hospital and diagnostics segments.
Financial Performance Overview
For the fourth quarter of FY26, Fortis Healthcare delivered a consolidated revenue of INR 2,365 crore, representing a 17.8% year-on-year increase. The company’s consolidated profit after tax reached INR 271 crore for the quarter, up 44.2%. For the full fiscal year 2026, the company achieved total revenues of INR 9,128 crore, an increase of 17.3%, while the annual profit after tax stood at INR 1,064 crore, marking a 31.5% growth over the previous year.
Segment-Wise Growth
The hospital business continues to be the primary revenue driver, contributing 85% to the total revenue. Hospital segment revenue grew by 19.1% to reach INR 7,773 crore in FY26. Key specialties including cardiac, orthopedics, neurology, gastroenterology, oncology, and renal sciences collectively grew by 18.9%, underscoring the company’s focus on clinical excellence. Furthermore, robotic surgeries witnessed a significant surge of 66% year-on-year.
The diagnostics business also demonstrated resilience, reporting gross revenues of INR 1,527 crore for FY26, reflecting a 8.5% increase. Operating EBITDA for the diagnostics segment improved significantly by 44.7%, reaching INR 360 crore, driven by network expansion and an increased focus on the preventive health portfolio.
Strategic Expansion and Future Outlook
Fortis continued its inorganic growth strategy throughout FY26, successfully acquiring People Tree Hospital in Bengaluru and Shrimann Hospital in Jalandhar. These additions, along with new operations and management agreements, have added approximately 500 beds to the network. As of March 31, 2026, the company operates 36 healthcare facilities with approximately 6,100 operational beds. Looking ahead, the company has planned a capacity addition of approximately 1,800 beds from FY27 to FY30, positioning itself for sustained long-term growth.
Source: BSE
